Relapsed or Refractory Mantle Cell Lymphoma

Also known as: Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00441	Gemcitabine	2	Completed	1
DB01204	Mitoxantrone	2	Completed	1
DB00073	Rituximab	2	Completed	1
DB09053	Ibrutinib	Not Available	Approved for Marketing	1